Skip to main content
Revvity logo
Contact us
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Products
  • 研究・開発
  • タンパク質解析
  • イムノアッセイ
  • Alphaアッセイ
  • AlphaLISA SureFire Biotin-Free Human Total MDMX Detection Kit, 50,000 Assay Points

AlphaLISA SureFire Biotin-Free Human Total MDMX Detection Kit, 50,000 Assay Points

AlphaLISA-SureFire-Biotin-Free-Total-Primary
AlphaLISA SureFire Biotin-Free Human Total MDMX Detection Kit, 50,000 Assay Points
AlphaLISA-SureFire-Biotin-Free-Total-Primary
AlphaLISA SureFire Biotin Free Total Kit Schematic

The AlphaLISA™ SureFire® Biotin-Free Human Total MDMX assay is a sandwich immunoassay for quantitative detection of total MDMX in cellular lysates using Alpha Technology.

View product information
Feature Specification
Application 細胞シグナル伝達
Protocol Time 2h at RT
Sample Volume 10 µL

The AlphaLISA™ SureFire® Biotin-Free Human Total MDMX assay is a sandwich immunoassay for quantitative detection of total MDMX in cellular lysates using Alpha Technology.

View product information
Product variants
Compare all
Remove all
Add to compare Add to compare
削除
Unit Size: 100 Assay Points
Part #:
ASBF-TMDMX-A-HV
Add to compare Add to compare
削除
Unit Size: 500 Assay Points
Part #:
ASBF-TMDMX-A500
Add to compare Add to compare
削除
Unit Size: 10,000 Assay Points
Part #:
ASBF-TMDMX-A10K
Add to compare Add to compare
削除
Unit Size: 50,000 Assay Points
Part #:
ASBF-TMDMX-A50K
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Request more information
AlphaLISA-SureFire-Biotin-Free-Total-Primary
AlphaLISA SureFire Biotin-Free Human Total MDMX Detection Kit, 50,000 Assay Points
AlphaLISA-SureFire-Biotin-Free-Total-Primary
AlphaLISA SureFire Biotin Free Total Kit Schematic

Loading...

Quick links
  • Variants
  • Product information
  • Resources
  • SDS, COAs, manuals and more
  • Related products
  • Get help

Product information

  • Overview
  • How it works
  • Assay validation
  • Assay versatility
  • Assay sensitivity
  • Specifications

Overview

MDMX (also known as MDM4) is a key negative regulator of the tumor suppressor p53, functioning as an oncogenic driver in a wide range of human cancers. MDMX binds to the p53 transactivation domain, inhibiting its transcriptional activity and promoting p53 degradation through recruitment of the E3 ubiquitin ligase MDM2. MDMX is structurally similar to MDM2 but lacks intrinsic ubiquitin ligase activity, instead acting as an allosteric activator of MDM2. The MDMX-p53 interaction is a critical node in the p53 signaling axis, and its dysregulation is a common mechanism by which cancer cells evade p53-mediated cell cycle arrest and apoptosis. MDMX is frequently amplified or overexpressed in tumors with wild-type p53, and small-molecule inhibitors that disrupt the MDMX-p53 interaction have emerged as a promising therapeutic strategy for restoring p53 function in cancers driven by MDMX deregulation. Quantitative assessment of MDMX expression and its relationship to p53 status can provide valuable insights into the underlying biology of p53-deficient cancers and guide the development of targeted p53-reactivating therapies.

The AlphaLISA SureFire Biotin-Free Human Total MDMX Detection Kit is a sandwich immunoassay for the quantitative detection of total MDMX in cellular lysates, using Alpha Technology.

Formats:

  • The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
  • The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
  • The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
  • The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Biotin Free kits are compatible with:

  • Cell and tissue lysates
  • Antibody modulators
  • Biotherapeutic antibodies
  • Biotin rich samples

AlphaLISA SureFire Biotin Free kits can be used for:

  • Cellular kinase assays
  • Receptor activation studies
  • High-throughput screening for preclinical studies

How it works

Total-AlphaLISA SureFire Biotin Free assay principle

The Total-AlphaLISA SureFire Biotin Free assay measures the expression level of a target protein in a biological sample (e.g. cell lysate).

The Total-AlphaLISA SureFire Biotin Free assay uses two antibodies which recognize two different distal epitopes on the target protein. AlphaLISA assays require two bead types: Acceptor and Donor Beads. Acceptor Beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor Beads are coated with a proprietary CaptSure3 agent to capture one of the detection antibodies, which is labeled with the CaptSure3 tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.

Total-AlphaLISA SureFire Ultra Biotin Free assay principle

 

Total-AlphaLISA SureFire Biotin Free two-plate assay protocol

The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Biotin Free detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.

2 plates assay protocol alphalisa surefire ultra biotin free total assay

Total-AlphaLISA SureFire Biotin Free one-plate assay protocol

Detection of Total target protein with AlphaLISA SureFire Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire quality.

1 plate assay protocol alphalisa surefire ultra biotin free total assay

Assay validation

Induction of MDMX expression in cells treated with IGF-1

MCF7 cells were seeded in a 96-well plate (4,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2.Cells were left untreated or treated with 1.25 µg/mL IGF-1 for 24 hours in serum free media.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). MDMX and ERK levels were evaluated using respective AlphaLISA SureFireBiotin Freeassays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

IGF-1 treatment induced a modest increase of MDMX expression while ERK levels remained unchanged.

Pharmacological Validation (Activation) of MDMX Total assay

Downregulation of MDMX expression in cells treated with HSP90 inhibitors

MCF7 cells were seeded in a 96-well plate (4,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2.Cells were treated with increasing concentrations of 17-AAG or SNX-2112 for 24 hours.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). MDMX and ERK levels were evaluated using respective AlphaLISA SureFireBiotin Freeassays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, HPS90 inhibitors resulted in a dose-dependent decrease of Total MDMX while ERK levels remained unchanged.

Pharmacological Validation (Inhibition) of MDMX Total assay
Pharmacological Validation (Inhibition) of MDMX Total assay

 

Doxorubicin induced downregulation of MDMX

MCF7 and HCT 116 cells were seeded in a 96-well plate (4,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2.Cells were treated with increasing concentrations of Doxorubicin for 24 hours.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). MDMX and ERK levels were evaluated using respective AlphaLISA SureFire Biotin Freeassays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

Doxorubicin treatment resulted in a dose-dependent decrease of MDMX while ERK levels remained unchanged.

Pharmacological Validation (Inhibition) of MDMX Total assay
Pharmacological Validation (Inhibition) of MDMX Total assay

Assay versatility

MDMX expression in various cell lines

Adherent cells were harvested and lysed with Lysis Buffer at a density of 4 x 106 cells/mL.

Suspension cells were harvested and lysed with Lysis Buffer at a density of 3.2 x 106 cells/mL.

Cells were lysed for 10 minutes at RT with shaking (350 rpm). MDMX levels were evaluated using the AlphaLISA SureFire Ultra Biotin Free assay. For the detection step, 10 µL of cell lysate (20,000 adherent cells or 15,000 suspension cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

MDMX protein is broadly expressed in various human cell lines.

Versatility of MDMX Total assay

Assay sensitivity

Assay sensitivity - cell lysate dilution

Cell lysate was prepared from MCF7 cells cultured to confluency in T175 flasks at 37°C, 5% CO2. Each flask was lysed in 2 mL of Lysis Buffer for 10 minutes at RT with shaking.

Lysate was serially diluted and MDMX levels were evaluated using the AlphaLISA SureFireBiotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

Approximate number of cells per datapoint is indicated. The dotted line represents assay background. The assay can detect MDMX expression in less than 1,000 cells/datapoint.

MDMX Total assay sensitivity

Specifications

Application
Cell Signaling
Automation Compatible
Yes
Brand
AlphaLISA SureFire Biotin-Free
Detection Modality
Alpha
Product Group
Kit
Protocol Time
2h at RT
Sample Volume
10 µL
Shipping Conditions
Shipped in Blue Ice
Target
MDMX
Target Class
Phosphoproteins
Target Species
Human
Technology
Alpha
Therapeutic Area
Oncology
Unit Size
50,000 Assay Points

Resources

Are you looking for resources, click on the resource type to explore further.

  • - Any -
  • Brochure:-:3
  • Guide:-:1
1-1 of 1 Resources
Guide Icon
Guide
AlphaLISA SureFire Ultra: the ultimate guide for successful experiments

The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay

Several biological processes are regulated by...

Learn more

Loading...

How can we help you?

We are here to answer your questions.

Contact sales I would like more product information Contact customer care Get technical support
Get Help Illustration Get Help Illustration
Revvity Logo

©2026 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.

Scroll Icon